Eikon Therapeutics, Inc.
EIKN
$10.73
$0.020.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | |||
|---|---|---|---|---|---|
| Net Income | 15.97% | -21.56% | -22.69% | ||
| Total Depreciation and Amortization | -18.69% | -19.36% | -17.86% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -85.64% | 6.51% | 83.89% | ||
| Change in Net Operating Assets | -63.58% | -351.92% | -10.85% | ||
| Cash from Operations | -98.43% | -64.71% | -75.75% | ||
| Capital Expenditure | 98.84% | 98.83% | 99.83% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 429.66% | -5.98% | -14.46% | ||
| Cash from Investing | 229.42% | 4.97% | 399.33% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -95.27% | 1,663,271.43% | 1,046.32% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -95.18% | -0.26% | 1,046.32% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 72.83% | -31.24% | 100.48% | ||